95TH GENERAL ASSEMBLY
State of Illinois
2007 and 2008
SB1324

 

Introduced 2/9/2007, by Sen. Jeffrey M. Schoenberg

 

SYNOPSIS AS INTRODUCED:
 
New Act

    Creates the Stem Cell Research and Human Cloning Prohibition Act. Permits research involving the derivation and use of human embryonic stem cells, human embryonic germ cells, and human adult stem cells from any source, including somatic cell nuclear transplantation, and allows public funding for stem cell research programs. Requires the Department of Public Health to develop and administer the Illinois Regenerative Medicine Institute program to provide for the awarding of grants to Illinois medical research institutions. Creates the Illinois Regenerative Medicine Institute Oversight Committee. Provides that a Committee member with a conflict of interest shall not vote upon or participate in any Committee action with respect to that matter. Requires each Committee member to file disclosures with the Secretary of State. Prohibits cloning or attempts to clone a human being. Prohibits the purchase or sale of embryonic or cadaveric fetal tissue for research purposes. Makes the purchase or sale of embryonic or cadaveric fetal tissue for research a Class A misdemeanor for the first conviction and a Class 4 felony for subsequent convictions.


LRB095 10721 RLC 30959 b

CORRECTIONAL BUDGET AND IMPACT NOTE ACT MAY APPLY
FISCAL NOTE ACT MAY APPLY

 

 

A BILL FOR

 

SB1324 LRB095 10721 RLC 30959 b

1     AN ACT concerning stem cell research.
 
2     Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
 
4     Section 1. Short title. This Act may be cited as the Stem
5 Cell Research and Human Cloning Prohibition Act.
 
6     Section 5. Policy permitting research. The policy of the
7 State of Illinois shall be as follows:
8     (1) Research involving the derivation and use of human
9 embryonic stem cells, human embryonic germ cells, and human
10 adult stem cells from any source, including somatic cell
11 nuclear transplantation, shall be permitted and the ethical and
12 medical implications of this research shall be given full
13 consideration.
14     (2) Research involving the derivation and use of human
15 embryonic stem cells, human embryonic germ cells, and human
16 adult stem cells, including somatic cell nuclear
17 transplantation, shall be allowed to receive public funds
18 through a program established specifically for the purpose of
19 supporting stem cell research in Illinois under the Department
20 of Public Health.
21     (3) Stem cell research is considered valuable to the health
22 and well being of all and the unhindered distribution of
23 research materials to all qualified investigators engaged in

 

 

SB1324 - 2 - LRB095 10721 RLC 30959 b

1 non-commercial research shall be encouraged within the
2 confines of the law.
 
3     Section 10. Definitions. As used in this Act:
4     "Department" means the Department of Public Health.
5     "Institute" means the Illinois Regenerative Medicine
6 Institute.
7     "Committee" means the Illinois Regenerative Medicine
8 Institute Oversight Committee.
 
9     Section 15. Department grant program.
10     (a) The Department of Public Health shall develop and
11 administer the Illinois Regenerative Medicine Institute
12 Program within the Department to provide for the awarding of
13 grants to Illinois medical research institutions.
14     (b) The purposes of the Institute grant program are:
15         (1) to improve the health of the citizens of Illinois
16     through stem cell research;
17         (2) to support scientific research in Illinois for
18     which funding from the U.S. government is currently
19     restricted, namely human embryonic stem cell research;
20         (3) to improve the national competitive position of
21     Illinois in the field of regenerative medicine; and
22         (4) to promote the translation of stem cell research
23     into clinical practice and the transfer of technology to
24     biomedical and technological industry.

 

 

SB1324 - 3 - LRB095 10721 RLC 30959 b

1     (c) The Department shall adopt rules for the implementation
2 of the Institute grant program, including but not limited to:
3         (1) rules for the solicitation of proposals for grants;
4         (2) rules concerning the eligibility of nonprofit
5     Illinois medical research institutions to receive awards
6     under the Institute grant program;
7         (3) rules for the conduct of competitive and scientific
8     peer review of all proposals submitted under the Institute
9     grant program;
10         (4) rules for the procurement of materials for the
11     conduct of stem cell research, including rules ensuring
12     that persons are empowered to make voluntary and informed
13     decisions to participate or to refuse to participate in
14     such research, and ensuring confidentiality of such
15     decisions; and
16         (5) rules concerning the monitoring of funded research
17     to ensure the researcher is following current best
18     practices with respect to medical ethics, including
19     informed consent of patients and the protection of human
20     subjects.
 
21     Section 20. Illinois Regenerative Medicine Institute
22 Oversight Committee.
23     (a) The Illinois Regenerative Medicine Institute Oversight
24 Committee shall be established to determine the awards under
25 the Institute grant program. The Committee shall be composed of

 

 

SB1324 - 4 - LRB095 10721 RLC 30959 b

1 7 members appointed by the Governor, with the advice and
2 consent of the Senate.
3     (b) The Committee shall consist of individuals from:
4         (1) professional medical organizations;
5         (2) voluntary health organizations; and
6         (3) for-profit biomedical or biotechnology industry.
7     (c) The Committee shall at all times include at least one
8 member from each of the 3 categories listed in subsection (b)
9 of this Section.
10     (d) No member of the Committee shall be employed by an
11 Illinois medical research institution eligible to receive
12 awards under the Institute grant program.
13     (e) Upon appointment, the Governor shall designate 3
14 members to serve a 2-year term and 4 members to serve a 4-year
15 term. The Committee shall designate a Chairperson,
16 Vice-Chairperson, and Secretary. Any vacancy occurring in the
17 membership of the Committee shall be filled in the same manner
18 as the original appointment.
19     (f) No member of the Committee may receive compensation for
20 his or her services, but each member may be reimbursed for
21 expenses incurred in the performance of his or her duties.
22     (g) The duties and responsibilities of the Committee shall
23 include, but not be limited to:
24         (1) determination of awards under the Institute grant
25     program, based on recommendations developed under the
26     competitive and scientific peer review process provided

 

 

SB1324 - 5 - LRB095 10721 RLC 30959 b

1     for in subdivision (c) (3) of Section 15 of this Act;
2         (2) review of the Department's solicitation and
3     scientific peer review processes to ensure that the
4     statutory purposes of the Institute grant program are met;
5         (3) development, in cooperation with Department staff,
6     general guidelines for the conduct of funded research
7     according to current best practices with respect to medical
8     ethics, in consultation with national and international
9     experts such as the International Society for Stem Cell
10     Research, the California Institute for Regenerative
11     Medicine, the Institute of Medicine, and similar
12     organizations; and
13         (4) advice on the future conduct of the Institute grant
14     program.
 
15     Section 25. Conflict of interest.
16     (a) A person has a conflict of interest if any Committee
17 action with respect to a matter may directly or indirectly
18 financially benefit any of the following:
19         (1) That person.
20         (2) That person's spouse, immediate family living with
21     that person, or that person's extended family.
22         (3) Any individual or entity required to be disclosed
23     by that person.
24         (4) Any other individual or entity with which that
25     person has a business or professional relationship.

 

 

SB1324 - 6 - LRB095 10721 RLC 30959 b

1     (b) A Committee member who has a conflict of interest with
2 respect to a matter may not discuss that matter with other
3 Committee members and shall not vote upon or otherwise
4 participate in any Committee action with respect to that
5 matter. Each recusal occurring during a Committee meeting shall
6 be made a part of the minutes or recording of the meeting in
7 accordance with the Open Meetings Act.
8     (c) The Institute shall not allow any Institute employee to
9 participate in the processing of, or to provide any advice
10 concerning, any matter with which the Institute employee has a
11 conflict of interest.
 
12     Section 30. Disclosure of Committee member income and
13 interests.
14     (a) Each Committee member shall file with the Secretary of
15 State a written disclosure of the following with respect to the
16 member, the member's spouse, and any immediate family living
17 with the member:
18         (1) Each source of income.
19         (2) Each entity in which the member, spouse, or
20     immediate family living with the member has an ownership or
21     distributive income share that is not an income source
22     required to be disclosed under item (1) of this subsection
23     (a).
24         (3) Each entity in or for which the member, spouse, or
25     immediate family living with the member serves as an

 

 

SB1324 - 7 - LRB095 10721 RLC 30959 b

1     executive, officer, director, trustee, or fiduciary.
2         (4) Each entity with which the member, member's spouse,
3     or immediate family living with the member has a contract
4     for future income.
5     (b) Each appointed Committee member shall file the
6 disclosure required by subsection (a) of this Section at the
7 time the member is appointed and at the time of any
8 reappointment of that member.
9     (c) Each Committee member shall file an updated disclosure
10 with the Secretary of State promptly after any change in the
11 items required to be disclosed under this subsection with
12 respect to the member, the member's spouse, or any immediate
13 family living with the member.
14     (d) The requirements of Section 3A-30 of the Illinois
15 Governmental Ethics Act and any other disclosures required by
16 law apply to this Act.
17     (e) Filed disclosures shall be public records.
 
18     Section 35. Disclosure of proposed Institute funding
19 recipients.
20     (a) Each Institute request to the Committee for approval of
21 proposed stem cell research funding must be accompanied by a
22 written disclosure that identifies the proposed funding
23 recipient and any executives, officers, directors, trustees,
24 fiduciaries, owners, parent company, subsidiaries, affiliates,
25 and institutional or organizational host of the proposed

 

 

SB1324 - 8 - LRB095 10721 RLC 30959 b

1 funding recipient.
2     (b) A proposed Institute stem cell research funding request
3 shall not be approved by the Committee unless and until the
4 Committee receives the disclosure.
5     (c) Disclosures provided to the Committee are public
6 records.
 
7     Section 40. Cloning prohibited.
8     (a) No person may clone or attempt to clone a human being.
9 For purposes of this Section, "clone or attempt to clone a
10 human being" means to transfer to a uterus or attempt to
11 transfer to a uterus anything other than the product of
12 fertilization of an egg of a human female by a sperm of a human
13 male for the purpose of initiating a pregnancy that could
14 result in the creation of a human fetus or the birth of a human
15 being.
16     (b) A person who violates this Section is guilty of a Class
17 A misdemeanor for the first conviction and a Class 4 felony for
18 subsequent convictions.
 
19     Section 45. Purchase or sale prohibited.
20     (a) A person may not knowingly, for valuable consideration,
21 purchase or sell embryonic or cadaveric fetal tissue for
22 research purposes.
23     (b) For the purpose of this Section, the giving or
24 receiving of reasonable payment for the removal, processing,

 

 

SB1324 - 9 - LRB095 10721 RLC 30959 b

1 disposal, preservation, quality control, storage,
2 transplantation, or implantation of the tissue does not
3 constitute purchase or sale. This Section does not prohibit
4 reimbursement for removal, storage, or transportation of
5 embryonic or cadaveric fetal tissue for research purposes
6 pursuant to this Act.
7     (c) A person who knowingly purchases or sells embryonic or
8 cadaveric fetal tissue for research purposes in violation of
9 subsection (a) of this Section is guilty of a Class A
10 misdemeanor for the first conviction and a Class 4 felony for
11 subsequent convictions.
 
12     Section 50. Severability. If any provision of this Act or
13 its application to any person or circumstance is held invalid,
14 the invalidity of that provision or application does not affect
15 other provisions or applications of this Act that can be given
16 effect without the invalid provision or application.